rs367966318

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_000383.4(AIRE):​c.1450G>A​(p.Val484Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000935 in 1,572,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V484A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000094 ( 0 hom. )

Consequence

AIRE
NM_000383.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 0.907

Publications

3 publications found
Variant links:
Genes affected
AIRE (HGNC:360): (autoimmune regulator) This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012]
AIRE Gene-Disease associations (from GenCC):
  • autoimmune polyendocrine syndrome type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Myriad Women’s Health, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • familial isolated hypoparathyroidism due to impaired PTH secretion
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07039821).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIRENM_000383.4 linkc.1450G>A p.Val484Met missense_variant Exon 12 of 14 ENST00000291582.6 NP_000374.1 O43918-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIREENST00000291582.6 linkc.1450G>A p.Val484Met missense_variant Exon 12 of 14 1 NM_000383.4 ENSP00000291582.5 O43918-1

Frequencies

GnomAD3 genomes
AF:
0.0000922
AC:
14
AN:
151800
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000103
AC:
19
AN:
184352
AF XY:
0.000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000669
Gnomad ASJ exome
AF:
0.000234
Gnomad EAS exome
AF:
0.0000662
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000147
Gnomad OTH exome
AF:
0.000419
GnomAD4 exome
AF:
0.0000936
AC:
133
AN:
1420730
Hom.:
0
Cov.:
31
AF XY:
0.0000993
AC XY:
70
AN XY:
704668
show subpopulations
African (AFR)
AF:
0.0000909
AC:
3
AN:
33004
American (AMR)
AF:
0.0000484
AC:
2
AN:
41282
Ashkenazi Jewish (ASJ)
AF:
0.000316
AC:
8
AN:
25340
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38422
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81870
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37216
Middle Eastern (MID)
AF:
0.000180
AC:
1
AN:
5558
European-Non Finnish (NFE)
AF:
0.000101
AC:
111
AN:
1098882
Other (OTH)
AF:
0.000135
AC:
8
AN:
59156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000922
AC:
14
AN:
151800
Hom.:
0
Cov.:
31
AF XY:
0.000162
AC XY:
12
AN XY:
74132
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41308
American (AMR)
AF:
0.000131
AC:
2
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67920
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000153
Hom.:
0
Bravo
AF:
0.000113
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000126
AC:
1
ExAC
AF:
0.0000864
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Polyglandular autoimmune syndrome, type 1 Uncertain:4
Apr 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Jan 21, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 484 of the AIRE protein (p.Val484Met). This variant is present in population databases (rs367966318, gnomAD 0.02%). This missense change has been observed in individual(s) with AIRE-related conditions (PMID: 12843157, 26084028, 34573280). ClinVar contains an entry for this variant (Variation ID: 550499). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AIRE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Aug 24, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: AIRE c.1450G>A (p.Val484Met) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 215656 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in AIRE causing Autoimmune Polyglandular Syndrome Type 1 (0.00011 vs 0.0028), allowing no conclusion about variant significance. c.1450G>A has been reported in the literature in individuals affected with Autoimmune Disorders/Immunodeficiencies (Buzi_2003, Grossi_2021). These reports do not provide unequivocal conclusions about association of the variant with Autoimmune Polyglandular Syndrome Type 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: all classified the variant as of uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
7.3
DANN
Benign
0.95
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.070
N
LIST_S2
Benign
0.45
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.070
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.91
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.70
N
REVEL
Uncertain
0.39
Sift
Benign
0.20
T
Sift4G
Benign
0.14
T
Polyphen
0.80
P
Vest4
0.13
MVP
0.78
MPC
0.23
ClinPred
0.027
T
GERP RS
0.24
Varity_R
0.046
gMVP
0.18
Mutation Taster
=28/72
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367966318; hg19: chr21-45714333; API